期刊文献+

脊髓性肌萎缩症临床诊断与治疗研究进展 被引量:4

Recent advance in clinical diagnosis and treatment of spinal muscular atrophy
原文传递
导出
摘要 脊髓性肌萎缩症(spinal muscular atrophy,SMA)是一种常见的遗传性神经肌肉病,为常染色体隐性遗传.活产婴儿的发病率为1/6000~1/10 000,人群携带者频率为1/40~1/50[1];病变表现为进行性、对称性肢体近端和躯干肌肉无力、瘫痪和萎缩[2].运动神经元生存基因1 (survival motor neuron 1,SMNl)基因的纯合缺失或微小突变造成SMN蛋白表达量下降,而研究表明SMN蛋白对神经元细胞轴突的生长、神经肌肉接头的形成、RNA的轴浆运输都发挥了重要作用[3],其表达量下降导致了脊髓前角α运动神经元退化变性,进而肌肉无力.运动神经元生存基因1 (survival motor neuron2,SMN2)基因与SMN1基因高度同源,可以编码部分正常功能SMN蛋白,缓解SMA的临床症状.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2014年第5期528-530,共3页 Chinese Journal of Neuromedicine
基金 国家自然科学基金(81101328) 广东省自然科学基金博士启动项目(S2012040007745) 珠江科技新星专项(2013J2200050)
关键词 脊髓性肌萎缩症 临床诊断 干细胞 基因治疗 Spinal muscular atrophy Clinical diagnosis Stem cell Gene therapy
  • 相关文献

参考文献26

  • 1Liew WK,Kang PB.Recent developments in the treatment of Duchenne muscular dystrophy and spinal muscular atrophy[J].Ther Adv Neurol Disord,2013,6(3):147-160.
  • 2刘维亮,李芳(综述),麻宏伟(审校).儿童型脊髓性肌萎缩症遗传学研究进展[J].国际儿科学杂志,2010,37(5):540-541. 被引量:2
  • 3Fallini C,Bassell GJ,Rossoll W.Spinal muscular atrophy:the role of SMN in axonal mRNA regulation[J].Brain Res,2012,1462:81-92.
  • 4Wirth B,Brichta L,Hahnen E.Spinal muscular atrophy from gene to therapy[J].Semin Pediatr Neurol,2006,13(2):121-131.
  • 5Wang CH,Finkel RS,Bertini ES,et al.Consensus statement for standard of care in spinal muscular atrophy[J].J Child Neurol,2007,22(8):1027-1049.
  • 6Sucato DJ.Spine deformity in spinal muscular atrophy[J].J Bone Joint Surg Am,2007,89(5):148-154.
  • 7Montes J,McDermott MP,Martens WB,et al.Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy[J].Neurology,2010,74(10):833-838.
  • 8Ltnn MR,Wang CH.Spinal muscular atrophy[J].Lancet,2008,371(9630):2120-2133.
  • 9梁国安,周柏林.儿童脊髓性肌萎缩症的基因诊断研究进展[J].国外医学(遗传学分册),2005,28(5):281-284. 被引量:4
  • 10朱海燕,胡娅莉,李洁,杨滢,吴星.应用多重连接依赖性探针扩增技术进行脊髓性肌萎缩症的基因诊断及产前诊断[J].中华医学遗传学杂志,2010,27(1):38-41. 被引量:6

二级参考文献37

  • 1ZHU Hai-yan,WU Ling-qian,PAN Qian,TANG Bei-sha,LIANG De-sheng,LONG Zhi-gao,DAI He-ping,XIA Kun,XIA Jia-hui.Rapid genetic diagnosis and prenatal diagnosis of spinal muscular atrophy by denaturing high-performance liquid chromatography[J].Chinese Medical Journal,2006(14):1222-1225. 被引量:5
  • 2Cartegni L,Hastings ML,Calarco JA,et al.Determinants of exon 7 splicing in the spinal muscular atrophy genes,SMNl and SMN2.Am J Hum Genet,2006,78(1):63-77.
  • 3Chen HH,Chang:JG,Lu RM,et al.The RNA binding protein hnRNP Q modulates the utilization of exon 7 in the survival motor neuron 2 (SMN2)gene.Mol Cell Biol,2008,28(22):6929-6938.
  • 4Singh NK,Singh NN,Androphy FJ,et al.Splicing of a critical exon of human survival motor neuron is regulated by a unique silencer ele ment located in the last intron.Mol Cell Biol,2006,26(4):1333-1346.
  • 5Wirth B.An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA).Hum Mutat,2000,15(3):228-237.
  • 6Simard LR,Rochette C,Semionov A,et al.SMN(T) and NAIP mutations in Canadian families with spinal muscular atrophy (SMA):genotype/phenotype correlations with disease severity.Am J Med Genet,1997,72(1):51-58.
  • 7Wirth B,Brichta L,Schrank B,et al.Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number.Hum Genet,2006,119(4):422-428.
  • 8Hauke J,Riessland M,Lunke S,et al.Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition.Hum Mol Genet,2009,18(2):304-317.
  • 9Skordis LA,Dunckley MG.Bifunctional antisense oligonucleotides provide a transacting splicing enhancer that simulates SMN2 gene expression in patient fibroblasts.Proc Nail Acad Sci USA,2003,100(7):4114-4119.
  • 10Ogino S,Wilson RB.Spinal muscular atrophy:molecular genetics and diagnostics.Expert Rev Mol Diagn,2004,4(1):15-29.

共引文献9

同被引文献39

  • 1江雨,周裕林.脊髓性肌萎缩症SMN1基因携带者筛查技术研究进展[J].中国产前诊断杂志(电子版),2013,5(2):34-39. 被引量:5
  • 2Liew W K, Kang P B. Recent developments in the treatment of duchenne muscular dystrophy and spinal muscular atrophy[J] - There Adv NeurolDisord, 2013, 6 (3): 147-160.
  • 3Russman B S. Spinal muscular atrophy- clinical classification and disease heterogeneity [J] . J ChiLd Neurology, 2007, 22- 946 951.
  • 4He J, Zhang Q J, Lin Q F, et al. Molecular analysis of SMN1, SMN2, NAIP, GTF2H2, and H4F5 genes in 157 Chinese patients with spinal muscular atrophy [J].Gene, 2013, 518 (2)- 325-329.
  • 5Fallini C, Bassell G J, Rossoll W. Spinal muscular atrophy- the role of SMN in axonal mRNA regulation [J]. Brain Res, 2012, 1462.- 81-92.
  • 6Mitrpant C, Porensky P, Zhou H, et al. Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript process ing: towards a treatment for spinal muscular atrophy -J- . PLOS One, 2013, 8 (4) : e62114.
  • 7Jiang W, Ji X, Xu Y, et al. Molecular prenatal diagnosis of autosomal recessive spinal muscular atrophies using quantificalion poly- merase chain reaction [J] . Genet Test Mol Biomarkers, 2013 , 17 (5) - 438-442.
  • 8Ogino S, Wilson RB. Genetic testing and risk assessment for spinal muscular atrophy(SMA) [ J ]. Hum Gene, 2002, 111 (6) : 477-500. DOI: 10. 1007/ s00439-002-0828-x.
  • 9Lefebvre S, Burglen L, Reboullet S, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell, 1995, 80(1): 155-165. DOI: 10. 1016/0092-8674 (95) 90460 -3.
  • 10Monani UR, Lorson CL, Parsons DW, et al. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2[ J]. Hum Mol Genet, 1999, 8 (7): 1177-1183. DOI: 10.1093/hmg/8. 7.1177.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部